Ureteral Reimplantation for Primary Obstructive Megaureter in Pediatric Patients: Is It Time for Robot-Assisted Approach?

Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A
PMID:

Abstract

To compare open and robotic approach for treatment of Primary Obstructive Megaureter (POM) in a series of pediatric patients. Medical records of all patients who had undergone ureteral reimplantation for POM at our institution, between January 2016 and December 2019, were retrospectively collected and analyzed. Open (Group B) and robotic (Group A) approach were compared. Success was defined as reduction of anteroposterior diameter of pelvis and ureter on postoperative ultrasound scan. Surgical complications were reported according to the Clavien-Dindo Classification. Esthetic results were compared through the Vancouver Scar Scale. Out of 23 patients, 11 belonged to Group A (5M and 6F) and 12 to Group B (9M and 3F). Median age at diagnosis was 38 months in Group A and 46 months in Group B ( = .69). Operative times were comparable (150' Group A and 140' Group B;  = .35), but the hospital stay was significantly shorter in the robotic group ( < .01). Success rate was comparable: 90.9% in Group A and 91.7% in Group B, respectively ( = ). Incidence of early complications was 9.1% in Group A (grade IIIB) and 8.3% in Group B (grade II) ( = ). Esthetic evaluation obtained a median score of 1 in Group A and 3 in Group B ( < .01). Our preliminary experience shows that robotic reimplantation can be a safe option in the treatment of POM in pediatric patients with clinical outcomes comparable to the open technique.

Authors

  • Simone Sforza
    Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Chiara Cini
    Department of Pediatric Urology, Meyer Hospital, University of Florence, Florence, Italy.
  • Elisa Negri
    Department of Pediatric Urology, Meyer Hospital, University of Florence, Florence, Italy.
  • Giulia Bortot
    Department of Pediatric Urology, Meyer Hospital, University of Florence, Florence, Italy.
  • Fabrizio Di Maida
    Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Gianmartin Cito
    Department of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Largo Brambilla, 3, 70134, Florence, Italy.
  • Maria Escolino
    Pediatric Surgery Unit, Department of Translational Medical Science, Federico II University, 80131 Naples, Italy.
  • Ciro Esposito
    Pediatric Surgery Unit, Department of Translational Medical Science, Federico II University, 80131 Naples, Italy.
  • Andrea Minervini
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Lorenzo Masieri